Pharmaceuticals, Biotechnology and Life Sciences
INT230-6 well tolerated at all doses given Durable clinical benefit seen in multiple patients Increases in circulating and intratumoral CD4…
Longest Follow-Up Data for KEYTRUDA in Lung Cancer to Date Showed Five-Year Overall Survival Rate of 23.2% with KEYTRUDA in…
In exploratory analysis of ARIEL3 data, Rubraca significantly improved clinically meaningful endpoints including chemotherapy free interval and PFS on next…
New Clinical Data Presented at the 2019 American Society of Clinical Oncology (ASCO) in Chicago, IL DUBLIN & BURLINGAME, Calif.–(BUSINESS…
Evaluation based upon market impact, plus vision and capability Medidata positioned as top company for impact created in market, which…
Phase 3 results featured in oral presentation at ASCO 2019, selected for Best of ASCO 2019 Meetings, and simultaneously published…
SALT LAKE CITY–(BUSINESS WIRE)–BioUtah and Utah’s life sciences industry is proud to congratulate one of its own—Fred Lampropoulos, founder and…
WASHINGTON–(BUSINESS WIRE)–Today, the Biotechnology Innovation Organization (BIO) released the 2019 Emerging Therapeutic Company Trend Report, highlighting ten years (2009-2018) of biotechnology…
PHILADELPHIA–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BIO2019?src=hash" target="_blank"gt;#BIO2019lt;/agt;–The 2019 BIO International Convention runs June 3 – 6, 2019 at the Pennsylvania Convention Center in…
Alpha Guardian Encourages Americans to Protect Our Families by Securing Firearms and Pharmaceuticals LAS VEGAS–(BUSINESS WIRE)–A recent study in JAMA…